Skip to main content
Premium Trial:

Request an Annual Quote

Patent Watch : Dec 12, 2008

Premium
Raven Biotechnologies has been awarded US Patent 7,462,487, “Cell culture media.”
 
The inventor listed on the patent is Mary Tsao.
 
The patent claims methods for culturing mammalian cells, preferably human cells, to improve production of recombinant or endogenous proteins, as stated in the abstract. Methods are also provided for the growth and long-term survival of cell lines, particularly cell lines established from primary culture. Cell culture media are described that contain varying levels of selected amino acids, supplemented with various growth factors and trace elements. The media are optionally serum free, and preferably use an energy source other than glucose. The media are particularly suitable for the primary and long-term culture of human fetal cells.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.